This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sloutsky, A.
Right arrow Articles by Werner, B. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sloutsky, A.
Right arrow Articles by Werner, B. G.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2004, p. 1547-1551, Vol. 42, No. 4
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.4.1547-1551.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Practical Strategies for Performance Optimization of the Enhanced Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test

A. Sloutsky,* L. L. Han, and B. G. Werner

Massachusetts State Laboratory Institute, Boston, Massachusetts

Received 21 August 2003/ Returned for modification 9 October 2003/ Accepted 6 January 2004

The enhanced Gen-Probe Amplified Mycobacterium Tuberculosis Direct (MTD) test was evaluated using a combined set of 338 acid-fast smear-positive and smear-negative, respiratory and nonrespiratory clinical specimens received by the Massachusetts State Tuberculosis Laboratory from September 1999 through March 2002. Microbiological culture was used as the reference method; therefore, the sensitivity and specificity of the MTD test were calculated for culture-positive specimens only. The initial assessment indicated that the overall sensitivity, specificity, and positive and negative predictive values of the MTD test for all specimens grouped together were 62, 98, 99, and 68%, respectively. A detailed discrepancy analysis revealed that two major factors causing negative MTD results in specimens that were culture positive for M. tuberculosis complex were patient treatment with antituberculosis drugs prior to testing and the presence of inhibitory substances in the specimen. Based on these findings, a protocol for optimizing MTD test performance in this setting is proposed in which (i) specimens from patients taking antituberculosis medications are excluded from testing and (ii) all initially MTD-negative or MTD-equivocal specimens are subjected to testing for inhibitors. If this strategy was followed, the MTD test sensitivity would be at least 91%, a significant improvement over the initial sensitivity of 62%. Accordingly, the negative predictive value would increase from 68 to 91%.

* Corresponding author. Mailing address: TB Laboratory, Massachusetts State Laboratory Institute, 305 South St., Boston, MA 02130. Phone: (617) 983-6370. Fax: (617) 983-6399. E-mail: alex.sloutsky{at}state.ma.us.

Journal of Clinical Microbiology, April 2004, p. 1547-1551, Vol. 42, No. 4
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.4.1547-1551.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Kim, J. Y., Ferraro, M. J., Branda, J. A. (2009). False-Negative Results Obtained with the Gen-Probe Amplified Mycobacterium tuberculosis Direct Test Caused by Unrecognized Inhibition of the Amplification Reaction. J. Clin. Microbiol. 47: 2995-2997 [Abstract] [Full Text]  
  • Guerra, R. L., Hooper, N. M., Baker, J. F., Alborz, R., Armstrong, D. T., Kiehlbauch, J. A., Conde, M. B., Dorman, S. E. (2008). Cost-Effectiveness of Different Strategies for Amplified Mycobacterium tuberculosis Direct Testing for Cases of Pulmonary Tuberculosis. J. Clin. Microbiol. 46: 3811-3812 [Abstract] [Full Text]  
  • Guerra, R. L., Baker, J. F., Alborz, R., Armstrong, D. T., Kiehlbauch, J. A., Conde, M. B., Dorman, S. E., Hooper, N. M. (2008). Specimen Dilution Improves Sensitivity of the Amplified Mycobacterium tuberculosis Direct Test for Smear Microscopy-Positive Respiratory Specimens. J. Clin. Microbiol. 46: 314-316 [Abstract] [Full Text]  
  • Guerra, R. L., Hooper, N. M., Baker, J. F., Alborz, R., Armstrong, D. T., Maltas, G., Kiehlbauch, J. A., Dorman, S. E. (2007). Use of the Amplified Mycobacterium tuberculosis Direct Test in a Public Health Laboratory: Test Performance and Impact on Clinical Care. Chest 132: 946-951 [Abstract] [Full Text]  
  • Zelazny, A. M., Calhoun, L. B., Li, L., Shea, Y. R., Fischer, S. H. (2005). Identification of Mycobacterium Species by secA1 Sequences. J. Clin. Microbiol. 43: 1051-1058 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»